Evidence map›Paper›PMID 40582840›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2025

RB and CHASER as induction therapy for transplant-eligible mantle cell lymphoma.

Toko Saito, Shigeru Kusumoto, Masamitsu Yanada, Seiichi Kato, Yoshitoyo Kagami, Yuka Kawaguchi, Hirofumi Taji, Shinya Hagiwara, Waki Hosoda, Kazuhito Yamamoto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Toko SaitoDepartment of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan.
Shigeru KusumotoDepartment of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan.
Masamitsu YanadaDepartment of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan.
Seiichi KatoDepartment of Pathology and Molecular Diagnostics, Aichi Cancer Center, Aichi, Japan.
Yoshitoyo KagamiDepartment of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan.
Yuka KawaguchiDepartment of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan.
Hirofumi TajiDepartment of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan.
Shinya HagiwaraDepartment of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan.
Waki HosodaDepartment of Pathology and Molecular Diagnostics, Aichi Cancer Center, Aichi, Japan.
Kazuhito YamamotoDepartment of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autologous peripheral blood cell transplantationinduction therapymantle cell lymphoma

Identifiers

PMID40582840
PMCPMC12351246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.